STRATA Skin Sciences to Report Second Quarter 2022 Financial Results on August 10, 2022
Rhea-AI Summary
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced plans to release its second quarter 2022 financial results on August 10, 2022, at 4:30 p.m. ET. The company will host a conference call to discuss these results and provide a corporate update, which will be available via webcast. STRATA specializes in developing and marketing innovative medical technologies for dermatologic conditions, including psoriasis and acne. Their offerings include excimer lasers and the new TheraClear®X Acne Therapy System.
Positive
- Plans to release Q2 2022 financial results indicating transparency.
- Introduction of the TheraClear®X Acne Therapy System expands product offerings.
Negative
- None.
News Market Reaction – SSKN
In the trading session that priced this news, SSKN declined 6.78%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HORSHAM, Pa., July 27, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its second quarter 2022 financial results on Wednesday, August 10, 2022. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast.
The link to the webcast will be available on the STRATA Skin Sciences website at:
www.strataskinsciences.com under the investor relations section and will be archived for future reference. To listen to the conference call, please dial 1-877-451-6152 (US/Canada), 1-201-389-0879 (International), and use the conference ID number 13730992.
About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing and marketing innovative products for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo, and acne. Its products include the XTRAC® and Pharos® excimer lasers, VTRAC® lamp systems, and now the TheraClear®X Acne Therapy System.
STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure versus an equipment purchase, installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice.
Investor Contact
Jack Droogan
(203) 585-4140
ir@strataskin.com
